CO-CarES: Tele-based Psychological Emotional Support for Informal CARegivers of COVID-19 Patients in Intensive Care

Sponsor
Rigshospitalet, Denmark (Other)
Overall Status
Recruiting
CT.gov ID
NCT04409821
Collaborator
(none)
50
6
1
20.1
8.3
0.4

Study Details

Study Description

Brief Summary

The experience of a loved one's stay in a COVID-19 intensive care unit (ICU), either intubated or on respiratory support, forces family caregivers (hereafter 'caregivers') to face core existential fears, such as uncertainty and death. It also poses a serious threat to basic human needs for autonomy, competence, and relatedness, as family caregivers have no control over the illness, and limited prior competence in dealing with critical illness. COVID-19 likely aggravates this experience, as social distancing cuts caregivers off from visiting patients in the ICU, from using their usual social supportive network and the threat of infection extends to caregivers themselves, their children and family. Combined, these extreme circumstances put caregivers in emotional turmoil and in need of psychological support and assistance in managing difficult emotions. ICU caregivers are at risk of developing clinically relevant symptoms of anxiety or posttraumatic stress. During the patient's ICU stay, caregivers experience peri-traumatic distress, such as helplessness, grief, frustration and anger, that may predict later posttraumatic stress disorder (PTSD). Symptoms of anxiety and PTSD may last for months to years after the patient's discharge. Further, caregivers of patients who die in an ICU may be at greater risk of prolonged grief disorder. Supportive interventions may reduce psychological late effects in ICU caregivers, but the primary focus of the majority of interventions has been on communication or surrogate decision making. The CO-CarES study aims to develop and test the feasibility of a tele-delivered psychological intervention to enable caregivers of ICU patients with COVID-19 to better endure the overwhelming uncertainty and emotional strain and reduce the risk of posttraumatic stress and prolonged grief. The study hypothesizes that providing psychological intervention during and after the patients' hospitalization, can decrease peri-traumatic distress during ICU hospitalization and decrease risk of post-traumatic stress, anxiety, depression and perceived stress following discharge, as well as prolonged grief in bereavement. A secondary hypothesis is that changes in emotion regulation mediate effects of the intervention on long-term psychological outcomes.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Tele-delivered psychological intervention
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Feasibility studyFeasibility study
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
COVID-19 Caregiver Emotional Support
Actual Study Start Date :
May 29, 2020
Anticipated Primary Completion Date :
Feb 1, 2022
Anticipated Study Completion Date :
Feb 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Tele-delivered psychological intervention

Weekly tele-delivered psychological intervention

Behavioral: Tele-delivered psychological intervention
The intervention consists of two (or one, if preferred by caregivers) weekly tele-sessions during the ICU stay, lasting up to 30 minutes, and two sessions in the month after discharge from or death in the ICU. Sessions will be conducted via phone-calls or video-conferencing. Therapists will 1) validate caregivers' subjective experience, 2) normalize and psychoeducate about emotional reactions, and 3) offer emotion regulation drawing on contemporary cognitive treatment packages of decentering, acceptance and emotion tolerance. Sessions for bereaved caregivers will include psycho-education about grief, assessment of risk for adverse outcomes and information about available support, if needed. The intervention will be performed based on an intervention manual. The content of the intervention will be continually adapted and tailored to the needs of the participating caregivers by involving all caregivers in co-creating the intervention trough brief post-session interviews.

Outcome Measures

Primary Outcome Measures

  1. Recruitment rate [At inclusion]

    Rate of consent among informed eligible participants

  2. Completion rate [During and post-intervention (1 month)]

    Rates of completion of intervention sessions among participants

  3. Peri-traumatic distress inventory (negative emotions) [Pre-post intervention (1 month after discharge/death)]

    Symptoms of peri-traumatic distress, min. score 0, max score 24, higher score corresponds to worse distress

  4. Impact of Events Scale (6 item) [1 month post intervention]

    Posttraumatic stress, min. score 6, max score 24, higher score corresponds to worse distress

  5. Impact of Events Scale (6 item) [6 months post intervention]

    Posttraumatic stress, min. score 6, max score 24, higher score corresponds to worse distress

  6. Impact of Events Scale (6 item) [12/13 months post intervention]

    Posttraumatic stress, min. score 6, max score 24, higher score corresponds to worse distress

Secondary Outcome Measures

  1. Prolonged Grief-13-scale [6 and 13 months]

    Prolonged Grief, scored according to diagnostic criteria for prolonged grief disorder

  2. PROMIS Depression (8 item scale) [Baseline to 1, 6, and 12/13 months]

    Symptoms of depression, min. score 8, max score 40, higher score corresponds to worse symptoms

  3. PROMIS Anxiety (8 item scale) [Baseline to 1, 6, and 12/13 months]

    Symptoms of anxiety, min. score 8, max score 40, higher score corresponds to worse symptoms

  4. Perceived Stress Scale (4 item) [Baseline to 1, 6, and 12/13 months]

    Perceived stress, min. score 0, max score 16, higher score corresponds to worse stress

Other Outcome Measures

  1. Short Penn State Worry Questionnaire (3 items) [Baseline to 1, 6, and 12/13 months]

    Worry, min. score 3, max score 15, higher score corresponds to greater worry

  2. Brooding subscale of Ruminative Responses Scale [Baseline to 1, 6, and 12/13 months]

    Brooding, min. score 5, max score 20, higher score corresponds to greater brooding/rumination

  3. Intolerance of uncertainty Scale (2 item) [Baseline to 1, 6, and 12/13 months]

    Intolerance of uncertainty, min score 2, max score 8, greater score indicates greater uncertainty intolerance

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • close relatives or friends of a patient hospitalized in an intensive care or intermediary care wards with COVID-19

  • capable of completing online questionnaires

  • speak Danish sufficiently for a therapeutic dialogue

  • provide informed consent

Exclusion Criteria:
  • suffering from a severe psychiatric disorder (such as schizophrenia) or in ongoing psychotherapeutic treatment for a psychiatric disorder (such as major depression generalized anxiety disorder or others), that cannot be paused

  • unable to complete verbal phone- or videoconferencing calls

  • unable to complete electronic questionnaires

Contacts and Locations

Locations

Site City State Country Postal Code
1 Skejby Hospital Aarhus Denmark
2 Rigshospitalet Copenhagen Denmark 2100
3 Hospitalsenheden Vest, Horsens Horsens Denmark
4 Hvidovre Hospital Hvidovre Denmark
5 Sygehus Lillebælt, Kolding Kolding Denmark
6 Odense University Hospital Odense Denmark

Sponsors and Collaborators

  • Rigshospitalet, Denmark

Investigators

  • Principal Investigator: Annika von Heymann, PhD, Department of Oncology, Rigshospitalet, Denmark

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Annika von Heymann, Postdoc, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT04409821
Other Study ID Numbers:
  • P-2020-544
  • 0216-00030B
First Posted:
Jun 1, 2020
Last Update Posted:
Feb 3, 2021
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Annika von Heymann, Postdoc, Rigshospitalet, Denmark
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 3, 2021